Glucocorticoid-induced osteoporosis

Clinical trials for Glucocorticoid-induced osteoporosis explained in plain language.

Never miss a new study

Get alerted when new Glucocorticoid-induced osteoporosis trials appear

Sign up with your email to follow new studies for Glucocorticoid-induced osteoporosis, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1 Completed 2

Can a bone drug fix steroid damage? new study aims to find out

Disease control Ongoing

This study tests if Prolia can improve bone density in people whose bones have weakened from taking steroids (glucocorticoids). About 102 adults in China will receive the drug and be monitored for 12 months. The main goal is to see if bone mass in the lower spine increases.

Matched conditions: GLUCOCORTICOID-INDUCED OSTEOPOROSIS

Phase 4 • Sponsor: Amgen • Aim: Disease control

Last updated Jun 27, 2026 12:37 UTC

Glucocorticoid-induced osteoporosis

Get alerted when new Glucocorticoid-induced osteoporosis trials appear

Can a bone drug fix steroid damage? new study aims to find out